175 related articles for article (PubMed ID: 27582552)
1. Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells.
Yin X; Zhang Y; Su J; Hou Y; Wang L; Ye X; Zhao Z; Zhou X; Li Y; Wang Z
Oncotarget; 2016 Oct; 7(41):66512-66524. PubMed ID: 27582552
[TBL] [Abstract][Full Text] [Related]
2. Rottlerin inhibits cell growth, induces apoptosis and cell cycle arrest, and inhibits cell invasion in human hepatocellular carcinoma.
Shi J; Ning H; He G; Huang Y; Wu Z; Jin L; Jiang X
Mol Med Rep; 2018 Jan; 17(1):459-464. PubMed ID: 29115596
[TBL] [Abstract][Full Text] [Related]
3. Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer.
Zheng N; Wang L; Hou Y; Zhou X; He Y; Wang Z
Cell Cycle; 2018; 17(21-22):2460-2473. PubMed ID: 30394832
[TBL] [Abstract][Full Text] [Related]
4. Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells.
Wang L; Hou Y; Yin X; Su J; Zhao Z; Ye X; Zhou X; Zhou L; Wang Z
Oncotarget; 2016 Oct; 7(43):69770-69782. PubMed ID: 27626499
[TBL] [Abstract][Full Text] [Related]
5. Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer.
Zhao Z; Zheng N; Wang L; Hou Y; Zhou X; Wang Z
Oncotarget; 2017 Jan; 8(5):7827-7838. PubMed ID: 27999199
[TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
Wang L; Ye X; Cai X; Su J; Ma R; Yin X; Zhou X; Li H; Wang Z
Oncotarget; 2015 Jul; 6(20):18027-37. PubMed ID: 26046466
[TBL] [Abstract][Full Text] [Related]
7. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells.
Su J; Wang L; Yin X; Zhao Z; Hou Y; Ye X; Zhou X; Wang Z
Am J Cancer Res; 2016; 6(10):2178-2191. PubMed ID: 27822410
[TBL] [Abstract][Full Text] [Related]
8. Rottlerin upregulates DDX3 expression in hepatocellular carcinoma.
Wang Z; Shen GH; Xie JM; Li B; Gao QG
Biochem Biophys Res Commun; 2018 Jan; 495(1):1503-1509. PubMed ID: 29203243
[TBL] [Abstract][Full Text] [Related]
9. Rottlerin promotes autophagy and apoptosis in gastric cancer cell lines.
Song J; Zhou Y; Gong Y; Liu H; Tang L
Mol Med Rep; 2018 Sep; 18(3):2905-2913. PubMed ID: 30015872
[TBL] [Abstract][Full Text] [Related]
10. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
Jane EP; Premkumar DR; Pollack IF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1070-80. PubMed ID: 16959960
[TBL] [Abstract][Full Text] [Related]
11. Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma.
Zhu Y; Wang M; Zhao X; Zhang L; Wu Y; Wang B; Hu W
Oncotarget; 2017 Apr; 8(14):22825-22834. PubMed ID: 28423559
[TBL] [Abstract][Full Text] [Related]
12. Nitidine chloride inhibited the expression of S phase kinase-associated protein 2 in ovarian cancer cells.
Mou H; Guo P; Li X; Zhang C; Jiang J; Wang L; Wang Q; Yuan Z
Cell Cycle; 2017 Jul; 16(14):1366-1375. PubMed ID: 28594256
[TBL] [Abstract][Full Text] [Related]
13. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
Sun SH; Huang HC; Huang C; Lin JK
Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells.
Liu Y; Zhou Z; Yan J; Wu X; Xu G
Biomed Res Int; 2020; 2020():8072639. PubMed ID: 32626765
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin.
Sun L; Cai L; Yu Y; Meng Q; Cheng X; Zhao Y; Sui G; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2007 Dec; 39(12):999-1007. PubMed ID: 18064393
[TBL] [Abstract][Full Text] [Related]
16. Rottlerin inhibits the nuclear factor kappaB/cyclin-D1 cascade in MCF-7 breast cancer cells.
Torricelli C; Fortino V; Capurro E; Valacchi G; Pacini A; Muscettola M; Soucek K; Maioli E
Life Sci; 2008 Mar; 82(11-12):638-43. PubMed ID: 18261747
[TBL] [Abstract][Full Text] [Related]
17. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.
Tillman DM; Izeradjene K; Szucs KS; Douglas L; Houghton JA
Cancer Res; 2003 Aug; 63(16):5118-25. PubMed ID: 12941843
[TBL] [Abstract][Full Text] [Related]
18. Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism.
Lim JH; Woo SM; Min KJ; Park EJ; Jang JH; Seo BR; Iqbal T; Lee TJ; Kim SH; Choi YH; Kwon TK
Chem Biol Interact; 2012 Apr; 197(1):1-7. PubMed ID: 22410117
[TBL] [Abstract][Full Text] [Related]
19. Multiple mechanisms of Rottlerin toxicity in A375 melanoma cells.
Ietta F; Valacchi G; Benincasa L; Pecorelli A; Cresti L; Maioli E
Biofactors; 2019 Nov; 45(6):920-929. PubMed ID: 31408224
[TBL] [Abstract][Full Text] [Related]
20. Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.
Li Z; Liu H; Li B; Zhang Y; Piao C
Cell Biochem Biophys; 2015 Jul; 72(3):719-26. PubMed ID: 25627547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
